Company dedicated to the development of potential therapies for neurodegenerative diseases
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | TARPLIN, DOWNS & YOUNG, LLC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— |
| Firm | Filings | Expenses |
|---|---|---|
| TARPLIN, DOWNS & YOUNG, LLC | 18 | — |
| Issue | Activities |
|---|---|
| Medicare/Medicaid | 18 |
| Health Issues | 18 |